TACR1 and hematologic disorder: To explore its functional role in hematological malignancies, we first assessed NK-1R expression in the peripheral blood samples of 17 patients with newly diagnosed AML (SI Appendix, Table S1) and 25 healthy volunteers by immunocytochemistry (Fig. 1A and SI Appendix, Fig. S1A).